|
|
||||||||
1 Laboratory of Pediatric Gastroenterology and Nutrition, 2 Experimental Surgery, and 3 Physiological Biochemistry, Christian de Duve Institute of Cellular and Molecular Pathology, Université Catholique de Louvain, 1200 Brussels, Belgium
The
postreceptor events regulating the signal of insulin
downstream in rat intestinal cells have not yet been analyzed. Our objectives were to identify the nature of receptor substrates and
phosphorylated proteins involved in the signaling of insulin and to
investigate the mechanism(s) by which insulin enhances intestinal
hydrolases. In response to insulin, the following proteins were rapidly
phosphorylated on tyrosine residues: 1) insulin receptor substrates-1 (IRS-1), -2, and -4; 2) phospholipase
C-isoenzyme-
; 3) the Ras-GTPase-activating protein (GAP)
associated with Rho GAP and p62Src; 4) the
insulin receptor
-subunit; 5) the p85 subunits of
phosphatidylinositol 3-kinase (PI 3-kinase); 6) the Src
homology 2
-collagen protein; 7) protein kinase B;
8) mitogen-activated protein (MAP) kinase-1 and -2; and
9) growth receptor-bound protein-2. Compared with controls,
insulin enhanced the intestinal activity of MAP kinase-2 and protein
kinase B by two- and fivefold, respectively, but did not enhance p70/S6
ribosomal kinase. Administration of an antireceptor antibody or
MAP-kinase inhibitor PD-98059 but not a PI 3-kinase inhibitor
(wortmannin) to sucklings inhibited the effects of insulin on mucosal
mass and enzyme expression. We conclude that normal rat enterocytes
express all of the receptor substrates and mediators involved in
different insulin signaling pathways and that receptor binding
initiates a signal enhancing brush-border membrane hydrolase, which
appears to be regulated by the cascade of MAP kinases but not by PI
3-kinase.
insulin receptor substrates; phosphotyrosine proteins; signal transduction
This article has been cited by other articles:
![]() |
C. Anderwald, G. Brabant, E. Bernroider, R. Horn, A. Brehm, W. Waldhausl, and M. Roden Insulin-Dependent Modulation of Plasma Ghrelin and Leptin Concentrations Is Less Pronounced in Type 2 Diabetic Patients Diabetes, July 1, 2003; 52(7): 1792 - 1798. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |